Cubist Pharmaceuticals Inc. v. Teva Parenteral Medicines Inc.
1:09-cv-00189
Overview
Parties
Defendant
Teva Parenteral Medicines Inc. Operating Company
Represented By
8 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Doungamon Fon Muttamara-Walker
District of Columbia Office of
Administrative Hearings, 441 Fourth Street, N.W.
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
5 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Doungamon Fon Muttamara-Walker
District of Columbia Office of
Administrative Hearings, 441 Fourth Street, N.W.
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
4 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Plaintiff
Cubist Pharmaceuticals Inc. Operating Company
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.
Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.
Agila Specialties Inc. et al. v. Cubist Pharmaceuticals Incorporated et al.
Agila Specialties Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.
Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC
Cubist Pharmaceuticals LLC v. Dr. Reddys Laboratories, Ltd.
Cubist Pharmaceuticals LLC v. Actavis LLC
Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc.
Cubist Pharmaceuticals Inc. v. Fresenius Kabi USA LLC
Cubist Pharmaceuticals LLC. v. Mylan Laboratories Limited
Cubist Pharmaceuticals Inc. v. Hospira Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6468967
Methods for administration of antibiotics
|
Filed: 1999-09-24
Issued: 2002-10-22
|
Expired (Term Ended)
Expires: 2019-09-24
|
|
|
US6852689
Methods for administration of antibiotics
|
Filed: 2002-02-20
Issued: 2005-02-08
|
Expired (Term Ended)
Expires: 2022-02-20
|
|
|
USRE39071
Anhydro-and isomer-a-21978c cyclic peptides
|
Filed: 2000-04-11
Issued: 2006-04-18
|
Expired (Term Ended)
Expires: 2020-04-11
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
0
Granted
0
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings